Terms: = Liver cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A AND Staging
145 results:
1. Development of a Model including MRI Features for Predicting Advanced-stage Recurrence of Hepatocellular Carcinoma after liver Resection.
Jiang H; Yang C; Chen Y; Wang Y; Wu Y; Chen W; Ronot M; Chernyak V; Fowler KJ; Bashir MR; Song B
Radiology; 2023 Nov; 309(2):e230527. PubMed ID: 37934100
[TBL] [Abstract] [Full Text] [Related]
2. Impact of EUS in liver transplantation workup for patients with unresectable perihilar cholangiocarcinoma.
de Jong DM; den Hoed CM; Willemssen FEJA; Thomeer MGJ; Bruno MJ; Koerkamp BG; de Jonge J; Alwayn IPJ; van Hooft JE; Hoogwater F; van der Heide F; Inderson A; van Vilsteren FGI; van Driel LMJW
Gastrointest Endosc; 2024 Apr; 99(4):548-556. PubMed ID: 37890597
[TBL] [Abstract] [Full Text] [Related]
3. [Expert consensus on precise diagnosis and management of primary hepatocellular carcinoma in advanced stage (2023 version)].
; ;
Zhonghua Gan Zang Bing Za Zhi; 2023 Sep; 31(9):910-920. PubMed ID: 37872086
[TBL] [Abstract] [Full Text] [Related]
4. Development and Validation of Prognostic Nomograms for Lung Squamous Cell Carcinoma With Brain Metastasis in Patients Aged 45 Years or Older: A Population-Based Study.
Yang F; Gao L; Wang Q; Gao W
Cancer Control; 2023; 30():10732748231202953. PubMed ID: 37776257
[TBL] [Abstract] [Full Text] [Related]
5. Cost-effectiveness and prognostic model of hepatic arterial infusion chemotherapy for hepatocellular carcinoma with high tumor burden and/or Vp4 tumor thrombus compared with sorafenib: a post-hoc analysis of the FOHAIC-1 trial.
Chen QF; Lyu N; Wang X; Jiang XY; Hu Y; Chen S; Zhong SX; Huang ZL; Chen M; Zhao M
Int J Surg; 2023 Dec; 109(12):3929-3939. PubMed ID: 37678272
[TBL] [Abstract] [Full Text] [Related]
6. ERS: A simple scoring system to predict early recurrence after surgical resection for hepatocellular carcinoma.
Costentin C; Audureau E; Park YN; Langella S; Vibert E; Laurent A; Cauchy F; Scatton O; Chirica M; Rhaiem R; Boleslawski E; di Tommaso L; Ferrero A; Yano H; Akiba J; Donadon M; Nebbia M; Detry O; Honoré P; Di Martino M; Schwarz L; Barbier L; Nault JC; Rhee H; Lim C; Brustia R; Paradis V; Guettier C; Le Bail B; Okumura S; Blanc JF; Calderaro J
Liver Int; 2023 Nov; 43(11):2538-2547. PubMed ID: 37577984
[TBL] [Abstract] [Full Text] [Related]
7. Role of rapid arc-image-guided radiotherapy in hepatocellular carcinoma with portal vein tumor thrombosis: A study from tertiary care center in Punjab, India.
Sidhu MS; Ramandeep ; Sood S; Aggarwal R; Singh K; Sood D
J Cancer Res Ther; 2023; 19(3):639-643. PubMed ID: 37470587
[TBL] [Abstract] [Full Text] [Related]
8. Comprehensive prognostic and immunological analysis of Ubiquitin Specific Peptidase 28 in pan-cancers and identification of its role in hepatocellular carcinoma cell lines.
Zhou W; Chen J; Wang J
Aging (Albany NY); 2023 Jul; 15(13):6545-6576. PubMed ID: 37450415
[TBL] [Abstract] [Full Text] [Related]
9. Development and validation of prognostic nomograms based on De Ritis ratio and clinicopathological features for patients with stage II/III colorectal cancer.
Fu J; Du F; Tian T; Huang H; Zhang L; Li D; Liu Y; Zhang D; Gao L; Zheng T; Liu Y; Zhao Y
BMC Cancer; 2023 Jul; 23(1):620. PubMed ID: 37400788
[TBL] [Abstract] [Full Text] [Related]
10. A spliceosome-associated gene signature aids in predicting prognosis and tumor microenvironment of hepatocellular carcinoma.
Wang H; Wang R; Fang J
Aging (Albany NY); 2023 Jun; 15(11):4906-4925. PubMed ID: 37301543
[TBL] [Abstract] [Full Text] [Related]
11. Nucleoporin 107 is a prognostic biomarker in hepatocellular carcinoma associated with immune infiltration.
Nong JS; Zhou X; Liu JQ; Luo JZ; Huang JM; Xie HX; Yang KJ; Wang J; Ye XP; Peng T
Cancer Med; 2023 May; 12(9):10990-11009. PubMed ID: 36952458
[TBL] [Abstract] [Full Text] [Related]
12. Estimating postsurgical outcomes of patients with a single hepatocellular carcinoma using gadoxetic acid-enhanced MRI: risk scoring system development and validation.
Park SH; Kim B; Kim S; Park S; Park YH; Shin SK; Sung PS; Choi JI
Eur Radiol; 2023 May; 33(5):3566-3579. PubMed ID: 36933020
[TBL] [Abstract] [Full Text] [Related]
13. Implications for surveillance for breast cancer patients based on the internally and externally validated BRENDA-metastatic recurrence score.
Ebner F; Salmen J; Dayan D; Kiesel M; Wolters R; Janni W; Wöckel A; Wischnewsky M
Breast Cancer Res Treat; 2023 May; 199(1):173-184. PubMed ID: 36917303
[TBL] [Abstract] [Full Text] [Related]
14. Preoperative Radiomics Nomogram Based on CT Image Predicts Recurrence-Free Survival After Surgical Resection of Hepatocellular Carcinoma.
Li Z; Yu J; Li Y; Liu Y; Zhang M; Yang H; Du Y
Acad Radiol; 2023 Aug; 30(8):1531-1543. PubMed ID: 36653278
[TBL] [Abstract] [Full Text] [Related]
15. Radiomics: A radiological evidence-based artificial intelligence technique to facilitate personalized precision medicine in hepatocellular carcinoma.
Wei J; Jiang H; Zhou Y; Tian J; Furtado FS; Catalano OA
Dig Liver Dis; 2023 Jul; 55(7):833-847. PubMed ID: 36641292
[TBL] [Abstract] [Full Text] [Related]
16. Prognostic nomograms for HBV-related BCLC 0-a stage hepatocellular carcinoma incorporating aspartate aminotransferase to albumin ratio.
Wu Y; Peng W; Shen J; Zhang X; Li C; Wen TF
Scand J Gastroenterol; 2023 Jul; 58(7):789-797. PubMed ID: 36620916
[TBL] [Abstract] [Full Text] [Related]
17. Mac-2 binding protein glycosylation isomer (M2BPGi) to evaluate liver fibrosis and cancer in HBV-infected patients in West Africa.
Vincent JP; Ndow G; Ogawa S; Ceesay A; Njie R; Sanneh B; Baldeh I; D'Alessandro U; Mendy M; Thursz M; Chemin I; Tanaka Y; Lemoine M; Shimakawa Y
J Glob Health; 2022 Nov; 12():04076. PubMed ID: 36370422
[TBL] [Abstract] [Full Text] [Related]
18. Monitoring quality of care in hepatocellular carcinoma: A modified Delphi consensus.
Maharaj AD; Lubel J; Lam E; Clark PJ; Duncan O; George J; Jeffrey GP; Lipton L; Liu H; McCaughan G; Neo EL; Philip J; Strasser SI; Stuart K; Thompson A; Tibballs J; Tu T; Wallace MC; Wigg A; Wood M; Zekry A; Greenhill E; Ioannou LJ; Ahlenstiel G; Bowers K; Clarke SJ; Dev A; Fink M; Goodwin M; Karapetis CS; Levy MT; Muller K; O'Beirne J; Pryor D; Seow J; Shackel N; Tallis C; Butler N; Olynyk JK; Reed-Cox K; Zalcberg JR; Roberts SK
Hepatol Commun; 2022 Nov; 6(11):3260-3271. PubMed ID: 36153817
[TBL] [Abstract] [Full Text] [Related]
19. LiSNet: An artificial intelligence -based tool for liver imaging staging of hepatocellular carcinoma aggressiveness.
Sun SW; Xu X; Liu QP; Chen JN; Zhu FP; Liu XS; Zhang YD; Wang J
Med Phys; 2022 Nov; 49(11):6903-6913. PubMed ID: 36134900
[TBL] [Abstract] [Full Text] [Related]
20. Identification of chromatin organization-related gene signature for hepatocellular carcinoma prognosis and predicting immunotherapy response.
Chen J; Chen X; Li T; Wang L; Lin G
Int Immunopharmacol; 2022 Aug; 109():108866. PubMed ID: 35691273
[TBL] [Abstract] [Full Text] [Related]
[Next]
